CTS written submission for the 2021 Federal Budget
The federal government should commit funding to ensure an adequate, accessible, and affordable national supply of personal protective equipment, medications and devices needed for treatment of respiratory illnesses. This would include investing in the domestic manufacturing of essential equipment and medicines.
The federal government should invest in improving access to programs, such as pulmonary rehabilitation, known to improve clinical outcomes for those living with respiratory diseases and to support the delivery of care for patients who have long term health consequences due to COVID-19.
The federal government should continue to invest in broad-based promotion of vaccinations, including but not limited to COVID-19 vaccines. This is an important measure to combat vaccine hesitancy in order to reduce pressures on Canada’s healthcare system and deliver better health outcomes for all Canadians.